On analysis by BC subtypes, estrogen/progesterone receptor (ER/PR)–positive and human epidermal growth factor receptor-2 (HER2/neu)–negative subgroups showed older DNAm age and increased age accel than their counterparts. This evidence concerns the gene ERBB2 and breast cancer.